Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.

Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, Giannikou K, Delakas D, Deltas C.

PLoS One. 2014 Mar 12;9(3):e91646. doi: 10.1371/journal.pone.0091646. eCollection 2014.

PMID:
24621579
[PubMed - in process]
2.

Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.

Hadjipanagi D, Chrysanthou S, Voskarides K, Deltas C.

BMC Res Notes. 2014 Mar 5;7:123. doi: 10.1186/1756-0500-7-123.

PMID:
24593903
[PubMed - in process]
3.

Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS.

Clin J Am Soc Nephrol. 2014 Mar;9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7.

PMID:
24509297
[PubMed - in process]
4.

X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.

Pierides A, Voskarides K, Kkolou M, Hadjigavriel M, Deltas C.

Hippokratia. 2013 Jul;17(3):207-13. Review.

PMID:
24470729
[PubMed]
5.

CNVs-microRNAs interactions demonstrate unique characteristics in the human genome. An interspecies in silico analysis.

Dweep H, Georgiou GD, Gretz N, Deltas C, Voskarides K, Felekkis K.

PLoS One. 2013 Dec 2;8(12):e81204. doi: 10.1371/journal.pone.0081204. eCollection 2013.

PMID:
24312536
[PubMed - in process]
6.

Evidence for activation of the unfolded protein response in collagen IV nephropathies.

Pieri M, Stefanou C, Zaravinos A, Erguler K, Stylianou K, Lapathitis G, Karaiskos C, Savva I, Paraskeva R, Dweep H, Sticht C, Anastasiadou N, Zouvani I, Goumenos D, Felekkis K, Saleem M, Voskarides K, Gretz N, Deltas C.

J Am Soc Nephrol. 2014 Feb;25(2):260-75. doi: 10.1681/ASN.2012121217. Epub 2013 Nov 21.

PMID:
24262798
[PubMed - indexed for MEDLINE]
7.

Molecular genetics of familial hematuric diseases.

Deltas C, Pierides A, Voskarides K.

Nephrol Dial Transplant. 2013 Dec;28(12):2946-60. doi: 10.1093/ndt/gft253. Epub 2013 Sep 17.

PMID:
24046192
[PubMed - in process]
8.

DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

International Alport Mutation Consortium, Savige J, Ars E, Cotton RG, Crockett D, Dagher H, Deltas C, Ding J, Flinter F, Pont-Kingdon G, Smaoui N, Torra R, Storey H.

Pediatr Nephrol. 2014 Jun;29(6):971-7. doi: 10.1007/s00467-013-2486-8. Epub 2013 May 30.

PMID:
23720012
[PubMed - in process]
9.

Epistatic role of the MYH9/APOL1 region on familial hematuria genes.

Voskarides K, Demosthenous P, Papazachariou L, Arsali M, Athanasiou Y, Zavros M, Stylianou K, Xydakis D, Daphnis E, Gale DP, Maxwell PH, Elia A, Pattaro C, Pierides A, Deltas C.

PLoS One. 2013;8(3):e57925. doi: 10.1371/journal.pone.0057925. Epub 2013 Mar 14.

PMID:
23516419
[PubMed - indexed for MEDLINE]
10.

Renal graft outcome in autosomal dominant medullary cystic kidney disease type 1.

Soloukides AP, Moutzouris DA, Papagregoriou GN, Stavrou CV, Deltas CC, Tzanatos HA.

J Nephrol. 2013 Jul-Aug;26(4):793-8. doi: 10.5301/jn.5000249. Epub 2013 Feb 25.

PMID:
23475468
[PubMed - indexed for MEDLINE]
11.

A mathematical model of the unfolded protein stress response reveals the decision mechanism for recovery, adaptation and apoptosis.

Erguler K, Pieri M, Deltas C.

BMC Syst Biol. 2013 Feb 21;7:16. doi: 10.1186/1752-0509-7-16.

PMID:
23433609
[PubMed - indexed for MEDLINE]
12.

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.

Adv Exp Med Biol. 2013;735:189-96. Review.

PMID:
23402027
[PubMed - indexed for MEDLINE]
13.

On 'Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations'.

Voskarides K, Pierides A, Deltas C.

Kidney Int. 2013 Feb;83(2):331. doi: 10.1038/ki.2012.376. No abstract available.

PMID:
23364590
[PubMed - indexed for MEDLINE]
14.

Is suppression of cyst growth in PKD enough to preserve renal function?: STAT6 inhibition is a novel promising target.

Deltas C, Felekkis K.

JAKSTAT. 2012 Jul 1;1(3):216-8. doi: 10.4161/jkst.21634.

PMID:
24058776
[PubMed]
15.

Genotype-phenotype correlation in X-linked Alport syndrome patients carrying missense mutations in the collagenous domain of COL4A5.

Tsiakkis D, Pieri M, Koupepidou P, Demosthenous P, Panayidou K, Deltas C.

Clin Genet. 2012 Sep;82(3):297-9. doi: 10.1111/j.1399-0004.2012.01849.x. Epub 2012 Feb 16. No abstract available.

PMID:
22335431
[PubMed - indexed for MEDLINE]
16.

A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.

Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN, Deltas C.

PLoS One. 2012;7(2):e31021. doi: 10.1371/journal.pone.0031021. Epub 2012 Feb 2.

PMID:
22319602
[PubMed - indexed for MEDLINE]
17.

Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria.

Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C.

Pediatr Nephrol. 2012 Apr;27(4):675-9. doi: 10.1007/s00467-011-2084-6. Epub 2012 Jan 8.

PMID:
22228437
[PubMed - indexed for MEDLINE]
18.

The role of molecular genetics in diagnosing familial hematuria(s).

Deltas C, Pierides A, Voskarides K.

Pediatr Nephrol. 2012 Aug;27(8):1221-31. doi: 10.1007/s00467-011-1935-5. Epub 2011 Jun 19. Review.

PMID:
21688191
[PubMed - indexed for MEDLINE]
19.

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.

PMID:
21566112
[PubMed - indexed for MEDLINE]
20.

Increased number of microRNA target sites in genes encoded in CNV regions. Evidence for an evolutionary genomic interaction.

Felekkis K, Voskarides K, Dweep H, Sticht C, Gretz N, Deltas C.

Mol Biol Evol. 2011 Sep;28(9):2421-4. doi: 10.1093/molbev/msr078. Epub 2011 Mar 25.

PMID:
21441354
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk